Ahem. Nothing written, appearing, or linked to, on this site is intended to be individual legal, or investment, advice. Consult a financial or legal adviser before making any trade, or any other decision, based anything you read, or see, on this website.
This website treats all U.S. viewers’ visitor-paths — and visits — as public data. If you are from Europe, understand that this site can see — but will not disclose to the public — your visitor-path, in compliance with applicable E.U. directives. We also (via enabled cookies) receive useful information about the device and software you use to access these pages, including IP address (from which location may be inferred), device type, web browser type, operating system version, phone carrier and manufacturer, member agents, application installations, device identifiers, mobile advertising identifiers, and push notification tokens. We do not sell any of this information, however — we are not for profit, here. We automatically receive information about your interactions with these pages, such as the posts or other content you view, the searches you conduct, the people you follow, and the dates and times of your visits. We may collect (for our own use only) information using cookies, pixel tags, and similar technologies. Cookies are small text files containing a string of alphanumeric characters. We may use both session cookies and persistent cookies. A session cookie disappears after you close your browser. A persistent cookie remains after you close your browser and may be used by your browser on subsequent visits to our pages.
All material on this website is derived from public documents, and/or edited, modified, and derived (in most cases) from public domain sources, or in some other cases, is originally-created by the author(s) of this site. Any use of any proprietary image, document or other non-public domain property or data is genuinely-intended by the author(s) to fall under the United States common-law “fair use” doctrine (as a means of clear identification of the parties involved — including Ms. Elizabeth Holmes, Sunny Balwani and her/his various current and former companies), and is offered as criticism of, and commentary on, matters of substantial public concern. Chief among these “matters of substantial public concern” are the felony tirals of both of them, separately, in 2021 and 2022, and more broadly, the for-profit health care systems, and new device, drug, vaccine and biologic approval policies here in the Americas [i.e., the central core of Theranos’s prior business model].
This site also examines how medical device companies use the protections of the US law — to shield executive officers, and large shareholders (like Ms. Holmes), from liability for felony level malfeasance, and breaches of fiduciary duty. There can scarcely be a more crying need for sunshine, than inside the often dark, and confusing labyrinth that is device pricing strategy, in the United States. if any of this offends Ms. Holmes or Mr. Balwani, so be it — she and he are public figures, as to all of these matters of substantial public concern, under applicable US law. [That would be the New York Times v. Sullivan and Gertz v. Welch jurisprudence.] Of course, if anyone wishes to dispute this site’s assertion of “fair use”, or any factual matter asserted here, please leave a comment in any of the comment-boxes, specifically-identifying the challenged material, and the basis for the challenge, on this site. The Site Administrator(s) will promptly consider the claim. In the same comment-box, the Site Administrator(s) will indicate the site’s position on any such claim. This site is entirely not-for-profit. Share, and share-a-like licenses granted in, and to, all content. Copy-left 2015-2021.
Holmes Felony Conviction And Incarceration 2023 